Maysaa Basha is a Neurology physician affiliated with Wayne State University. OpenAlex indexes 100 publications with 718 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4201 Saint Antoine St
Suite 8a & 8b
Detroit, MI 482012153
Telephone
313-745-4275Registry record last updated 25 May 2016.
Clinical trials
- Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
Sponsor: Wayne State University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SK Life Science, Inc.Program year20252 payments
- Neurelis, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
98.9%Other antiepileptics38.5%Lacosamide47%Levetiracetam25%Briviact15%Topiramate9%Xcopri5%Part D<11 patientsBenzodiazepine19.6%Clobazam64%Clonazepam20%Onfi10%Lorazepam6%Part D<11 patients+ 8 more classes in this area
Musculoskeletal
1.1%gamma-Aminobutyric Acid-ergic Agonist1.1%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling
Neurology Neuroimmunology & Neuroinflammation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Pranatharthi Chandrasekar, MD
Wayne State University
Gerold Bepler, MD
Wayne State University
Eishi Asano, MD
Wayne State University
Bret Hughes, MD
Wayne State University
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”